Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLakewood-Amedex Biotherapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$2.66 | -$2.66 | -$2.66 |
| Q2 2026 | 1 | -$0.81 | -$0.81 | -$0.81 |
| Q3 2026 | 1 | -$0.76 | -$0.76 | -$0.76 |
Lakewood-Amedex Biotherapeutics Inc. Earnings Date And Information
Lakewood-Amedex Biotherapeutics Inc. last posted its earnings results on Thursday, August 13th, 2026. The company reported $-2.75 earnings per share for the quarter, missing analysts' consensus estimates of $-2.66 by $0.09. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Lakewood-Amedex Biotherapeutics Inc. has generated $-3 earnings per share over the last year ($-2.76 diluted earnings per share) and currently has a price-to-earnings ratio of -0.2. Lakewood-Amedex Biotherapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Lakewood-Amedex Biotherapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2026 | Q2 2026 | N/A | -$2.75 | N/A | $0 | $0 |
| 05/22/2026 | Q1 2026 | N/A | -$2.00 | N/A | N/A | $0 |
| 12/31/2025 | Q4 2025 | N/A | -$3.90 | N/A | N/A | $0 |
| 09/30/2025 | Q3 2025 | N/A | -$1.37 | N/A | N/A | $0 |
| 06/30/2025 | Q2 2025 | N/A | -$1.66 | N/A | N/A | $0 |
| 03/31/2025 | Q1 2025 | N/A | -$1.50 | N/A | N/A | $0 |
| 12/31/2024 | Q4 2024 | N/A | $0.00 | N/A | N/A | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$2.79 | N/A | N/A | $0 |
| 06/30/2024 | Q2 2024 | N/A | -$1.53 | N/A | N/A | $0 |
| 03/31/2024 | Q1 2024 | N/A | -$1.46 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lakewood-Amedex Biotherapeutics Inc. Earnings: FAQ's
The conference call for Lakewood-Amedex Biotherapeutics Inc.'s latest earnings report can be listened to online.
The conference call transcript for Lakewood-Amedex Biotherapeutics Inc.'s latest earnings report can be read online.
Lakewood-Amedex Biotherapeutics Inc. (:LABT) has a recorded net income of $-3,847,637.Lakewood-Amedex Biotherapeutics Inc. has generated $-2.76 earnings per share over the last four quarters.
Lakewood-Amedex Biotherapeutics Inc. (:LABT) has a price-to-earnings ratio of -0.2 and price/earnings-to-growth ratio is 0.